Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Assertio Holdings Total Current Assets 2010-2024 | ASRT

Assertio Holdings total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  
Assertio Holdings Annual Total Current Assets
(Millions of US $)
2024 $203
2023 $171
2022 $132
2021 $103
2020 $94
2019 $104
2018 $208
2017 $231
2016 $306
2015 $309
2014 $618
2013 $337
2012 $95
2011 $109
2010 $80
2009 $78
Assertio Holdings Quarterly Total Current Assets
(Millions of US $)
2024-12-31 $203
2024-09-30 $181
2024-06-30 $178
2024-03-31 $172
2023-12-31 $171
2023-09-30 $185
2023-06-30 $134
2023-03-31 $138
2022-12-31 $132
2022-09-30 $126
2022-06-30 $117
2022-03-31 $125
2021-12-31 $103
2021-09-30 $113
2021-06-30 $119
2021-03-31 $124
2020-12-31 $94
2020-09-30 $104
2020-06-30 $135
2020-03-31 $180
2019-12-31 $104
2019-09-30 $124
2019-06-30 $139
2019-03-31 $182
2018-12-31 $208
2018-09-30 $227
2018-06-30 $127
2018-03-31 $193
2017-12-31 $231
2017-09-30 $219
2017-06-30 $219
2017-03-31 $287
2016-12-31 $306
2016-09-30 $261
2016-06-30 $230
2016-03-31 $293
2015-12-31 $309
2015-09-30 $303
2015-06-30 $232
2015-03-31 $613
2014-12-31 $618
2014-09-30 $632
2014-06-30 $310
2014-03-31 $313
2013-12-31 $337
2013-09-30 $111
2013-06-30 $98
2013-03-31 $96
2012-12-31 $95
2012-09-30 $105
2012-06-30 $97
2012-03-31 $115
2011-12-31 $109
2011-09-30 $125
2011-06-30 $130
2011-03-31 $158
2010-12-31 $80
2010-09-30 $79
2010-06-30 $75
2010-03-31 $71
2009-12-31 $78
2009-09-30 $80
2009-06-30 $77
2009-03-31 $88
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.058B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.840B 34.83
Zoetis (ZTS) United States $70.908B 26.46
Daiichi Sankyo, - (DSNKY) Japan $46.582B 23.70
Takeda Pharmaceutical (TAK) Japan $45.692B 9.09
Sandoz Group AG (SDZNY) Switzerland $20.090B 0.00
Merck (MKKGY) Germany $17.991B 14.89
Summit Therapeutics (SMMT) United States $17.794B 0.00
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.596B 12.03
Neurocrine Biosciences (NBIX) United States $11.451B 39.22
IPSEN (IPSEY) France $9.860B 0.00
Orion OYJ (ORINY) Finland $8.661B 23.42
Corcept Therapeutics (CORT) United States $7.448B 60.54
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.542B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.134B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Grifols, S.A (GRFS) Spain $4.882B 0.00
Soleno Therapeutics (SLNO) United States $3.869B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.873B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.850B 9.99
Hypermarcas (HYPMY) Brazil $2.486B 16.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.297B 12.56
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.017B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.741B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Guardian Pharmacy Services (GRDN) United States $1.622B 0.00
Indivior (INDV) United States $1.528B 6.48
Evotec AG (EVO) Germany $1.527B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 168.00
Dyne Therapeutics (DYN) United States $1.297B 0.00
Ocular Therapeutix (OCUL) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 44.44
Collegium Pharmaceutical (COLL) United States $0.928B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Enliven Therapeutics (ELVN) United States $0.904B 0.00
Harrow (HROW) United States $0.895B 0.00
Ardelyx (ARDX) United States $0.866B 0.00
Xeris Biopharma Holdings (XERS) United States $0.783B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.732B 0.00
Akebia Therapeutics (AKBA) United States $0.668B 0.00
Xencor (XNCR) United States $0.593B 0.00
KalVista Pharmaceuticals (KALV) United States $0.592B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.94
Bioventus (BVS) United States $0.547B 13.92
Regulus Therapeutics (RGLS) United States $0.521B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
CytoDyn (CYDY) United States $0.497B 0.00
Savara (SVRA) United States $0.494B 0.00
Elite Pharmaceuticals (ELTP) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.449B 0.00
Altimmune (ALT) United States $0.431B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.404B 8.45
Organogenesis (ORGO) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.07
Heron Therapeutics (HRTX) United States $0.322B 0.00
Aquestive Therapeutics (AQST) United States $0.277B 0.00
Nature's Sunshine Products (NATR) United States $0.253B 23.39
ProKidney (PROK) United States $0.211B 0.00
Wellgistics Health (WGRX) United States $0.195B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Avita Medical (RCEL) United States $0.184B 0.00
OmniAb (OABI) United States $0.176B 0.00
Nanobiotix S.A (NBTX) France $0.161B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Larimar Therapeutics (LRMR) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.14
Cassava Sciences (SAVA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 52.22
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Prelude Therapeutics (PRLD) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Surrozen (SRZN) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
DURECT (DRRX) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 8.31
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00